[ back to News ]
Concert Pharmaceuticals to Present at the Piper Jaffray 23rd Annual Healthcare Conference on November 30, 2011
November 21, 2011
Lexington, MA – Concert Pharmaceuticals, Inc. announced today that Roger Tung, Ph.D., President and Chief Executive Officer of Concert, will present at the 23rd Annual Piper Jaffray Health Care Conference on Wednesday, November 30, 2011 at 3:50 p.m. ET. The conference will be held November 29-30, 2011 at the New York Palace in New York City.
Concert Pharmaceuticals is a clinical stage
biotechnology company focused on applying the company’s DCE Platform™
(deuterated chemical entity platform) to create novel and differentiated small
molecule drugs. Concert’s approach leverages decades of pharmaceutical and
clinical experience to reduce the time, risk and expense needed to create
important new medicines. The company has a broad research pipeline encompassing
many therapeutic areas including antiviral disease, renal disease, and CNS
disorders, among others. Founded in 2006, Concert has raised more than $110
million of venture and institutional capital. For more information on Concert
Pharmaceuticals, please visit www.concertpharma.com.
Concert Pharmaceuticals, the CoNCERT logo and the
DCE Platform are trademarks of Concert Pharmaceuticals, Inc.
[ back to top ]